ticlopidine has been researched along with Proteinuria in 8 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the antiplatelet agents ticlopidine and dipyridamole on immune complex glomerulonephritis in rats was evaluated." | 7.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Mizumura, Y; Sasayama, S, 1986) |
| "The effect of the antiplatelet agents, ticlopidine and dipyridamole, on nephrotoxic serum nephritis (NTN) was evaluated in rats." | 7.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Sasayama, S, 1987) |
| "The present review focuses on the roles of thromboxane A2 (TxA2) in arterial thrombosis, atherogenesis, vascular stent-related ischemic events and renal proteinuria." | 4.85 | Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases. ( Alberts, P; Bounameaux, H; Fontana, P; Mann, J; Sakariassen, KS; Sorensen, AS, 2009) |
| "The effect of the antiplatelet agents ticlopidine and dipyridamole on immune complex glomerulonephritis in rats was evaluated." | 3.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Mizumura, Y; Sasayama, S, 1986) |
| "The effect of the antiplatelet agents, ticlopidine and dipyridamole, on nephrotoxic serum nephritis (NTN) was evaluated in rats." | 3.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Sasayama, S, 1987) |
| "The treatment with Valsartan combined with Clopidogrel and Leflunomide can reduce the urinary proteins loss and renal function deterioration for IgA nephropathy patients and cause minimal adverse reactions." | 2.80 | Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy. ( Chen, F; Cheng, G; Fang, Y; Guo, Y; Li, H; Liu, D; Liu, F; Liu, L; Liu, Z; Margetts, P; Tang, L; Zhao, Z, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davila, CD | 1 |
| Vargas, F | 1 |
| Huang, KH | 1 |
| Monaco, T | 1 |
| Dimou, A | 1 |
| Rangaswami, J | 1 |
| Figueredo, VM | 1 |
| Cheng, G | 1 |
| Liu, D | 1 |
| Margetts, P | 1 |
| Liu, L | 1 |
| Zhao, Z | 1 |
| Liu, Z | 1 |
| Tang, L | 1 |
| Fang, Y | 1 |
| Li, H | 1 |
| Guo, Y | 1 |
| Chen, F | 1 |
| Liu, F | 1 |
| Sakariassen, KS | 1 |
| Alberts, P | 1 |
| Fontana, P | 1 |
| Mann, J | 1 |
| Bounameaux, H | 1 |
| Sorensen, AS | 1 |
| Ogawa, S | 1 |
| Naruse, T | 1 |
| Riyuzo, MC | 1 |
| Soares, VA | 1 |
| Yamada, T | 1 |
| Tomioka, K | 1 |
| Horie, M | 1 |
| Sakurai, Y | 1 |
| Nagaoka, H | 1 |
| Mase, T | 1 |
| Izumino, K | 2 |
| Iida, H | 2 |
| Asaka, M | 2 |
| Mizumura, Y | 1 |
| Sasayama, S | 2 |
1 review available for ticlopidine and Proteinuria
| Article | Year |
|---|---|
Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Humans; | 2009 |
1 trial available for ticlopidine and Proteinuria
| Article | Year |
|---|---|
Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Biomarkers; China; Clopidogrel; Creatinine; Disease | 2015 |
6 other studies available for ticlopidine and Proteinuria
| Article | Year |
|---|---|
Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular events.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cohort Stud | 2015 |
Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
Topics: Animals; Anticoagulants; Aspirin; Batroxobin; Blood Platelets; Dipyridamole; Glomerulonephritis; Imm | 1982 |
Role of ticlopidine on adriamycin-induced nephropathy.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation, Preclinical; Kidney; Male; Nephr | 1999 |
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Mal | 1991 |
Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.
Topics: Animals; Antibodies; Antigen-Antibody Complex; Cattle; Creatinine; Dipyridamole; Fluorescent Antibod | 1986 |
Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats.
Topics: Animals; Dipyridamole; Immune Complex Diseases; Nephritis; Platelet Aggregation; Proteinuria; Rats; | 1987 |